Apyx Medical Corporation
APYX
$0.958
$0.0788.86%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -8.11% | -3.49% | 3.36% | 14.25% | 17.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.11% | -3.49% | 3.36% | 14.25% | 17.61% |
| Cost of Revenue | 0.82% | 11.55% | 12.64% | 16.86% | 20.88% |
| Gross Profit | -13.03% | -11.33% | -1.62% | 12.81% | 15.89% |
| SG&A Expenses | -10.66% | -5.36% | -0.20% | 1.37% | 0.77% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.40% | -0.73% | 3.91% | 6.24% | 6.60% |
| Operating Income | 5.54% | -6.10% | -5.11% | 9.10% | 14.42% |
| Income Before Tax | -9.52% | -60.11% | -55.36% | -0.91% | 7.11% |
| Income Tax Expenses | 110.36% | 110.56% | 93.60% | 94.31% | -762.67% |
| Earnings from Continuing Operations | -24.98% | -86.54% | -73.51% | -9.91% | 19.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.93% | -39.71% | -11.57% | -15.00% | 45.74% |
| Net Income | -25.38% | -87.67% | -74.14% | -10.06% | 19.28% |
| EBIT | 5.54% | -6.10% | -5.11% | 9.10% | 14.42% |
| EBITDA | 5.26% | -7.01% | -5.88% | 8.45% | 14.11% |
| EPS Basic | -23.04% | -87.53% | -73.88% | -9.79% | 19.55% |
| Normalized Basic EPS | -9.89% | -22.96% | -19.77% | -0.22% | 8.46% |
| EPS Diluted | -23.04% | -87.53% | -73.88% | -9.79% | 19.55% |
| Normalized Diluted EPS | -9.89% | -22.96% | -19.77% | -0.22% | 8.46% |
| Average Basic Shares Outstanding | 2.64% | 0.10% | 0.15% | 0.22% | 0.31% |
| Average Diluted Shares Outstanding | 2.64% | 0.10% | 0.15% | 0.22% | 0.31% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
